Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-15-002293
Filing Date
2015-03-16
Accepted
2015-03-16 17:01:23
Documents
17
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2223421z10-k.htm 10-K 1878705
2 EX-4.8 a2223421zex-4_8.htm EX-4.8 79178
3 EX-10.11 a2223421zex-10_11.htm EX-10.11 13952
4 EX-10.37 a2223421zex-10_37.htm EX-10.37 82892
5 EX-10.38 a2223421zex-10_38.htm EX-10.38 72887
6 EX-10.39 a2223421zex-10_39.htm EX-10.39 74550
7 EX-23.1 a2223421zex-23_1.htm EX-23.1 4681
8 EX-31.1 a2223421zex-31_1.htm EX-31.1 7812
9 EX-31.2 a2223421zex-31_2.htm EX-31.2 7858
10 EX-32.1 a2223421zex-32_1.htm EX-32.1 5840
17 G980995.JPG g980995.jpg GRAPHIC 42905
  Complete submission text file 0001047469-15-002293.txt   17577684

Data Files

Seq Description Document Type Size
11 EX-101.INS anac-20141231.xml EX-101.INS 3201789
12 EX-101.SCH anac-20141231.xsd EX-101.SCH 94189
13 EX-101.CAL anac-20141231_cal.xml EX-101.CAL 81330
14 EX-101.DEF anac-20141231_def.xml EX-101.DEF 337495
15 EX-101.LAB anac-20141231_lab.xml EX-101.LAB 847717
16 EX-101.PRE anac-20141231_pre.xml EX-101.PRE 581069
Mailing Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303
Business Address 1020 E. MEADOW CIRCLE PALO ALTO CA 94303 650-543-7500
Anacor Pharmaceuticals, Inc. (Filer) CIK: 0001411158 (see all company filings)

EIN.: 251854385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34973 | Film No.: 15703762
SIC: 2834 Pharmaceutical Preparations